Exciting news from the biotech world! Jupiter Neurosciences, Inc. ( $JUNS on #NASDAQ), a clinical-stage pharmaceutical company focused on addressing neuroinflammation and promoting healthy aging, has just received #FDA Clearance for its IND application to kick off a Phase 2a clinical trial of #JOTROL™ in Parkinson’s disease.
Market Data 
Markets 
AI
